<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <title>Privacy & Compliance | LiquidMammo™</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />

  <meta
    name="description"
    content="Privacy, data use, and compliance practices for LiquidMammo™ and MultiOmics Inc., including HIPAA alignment, consent, and participant protections."
  />

  <!-- Stylesheet -->
  assets/css/styles.css

  <!-- Favicon -->
  favicon.png
</head>

<body>

<!-- ======================================
     MINIMAL HEADER (← Home)
======================================= -->
<header class="container">
  <nav>
    index.html← Home</a>
  </nav>
</header>


<!-- ======================================
     MAIN CONTENT
======================================= -->
<main class="container">

  <h1>Privacy & Compliance</h1>

  <!-- Overview -->
  <section class="section-tight">
    <p>
      MultiOmics Inc. maintains strict privacy, consent, and data‑security practices to protect
      patient and clinical information associated with LiquidMammo™, our microRNA‑based supplemental screening test.
    </p>

    <p class="notice" style="margin-top:14px;">
      LiquidMammo is being developed as a <strong>CLIA Laboratory Developed Test (LDT)</strong>.
      It is not yet FDA‑cleared or FDA‑approved.
    </p>
  </section>


  <!-- HIPAA -->
  <section class="panel-light section-tight">
    <h2>HIPAA alignment</h2>

    <ul class="list-tight">
      <li>All Protected Health Information (PHI) is handled under HIPAA‑aligned workflows.</li>
      <li>PHI is encrypted at rest and in transit.</li>
      <li>Access is restricted to authorized clinical and laboratory staff.</li>
      <li>Audit logs track all PHI access and modifications.</li>
      <li>No PHI is shared externally without authorization.</li>
    </ul>
  </section>


  <!-- Consent -->
  <section class="section-tight">
    <h2>Consent & data use</h2>

    <p>
      All patient samples and associated information follow informed‑consent pathways that specify
      permitted uses and data‑sharing restrictions.
    </p>

    <ul class="list-tight" style="margin-top:10px;">
      <li>Consent scopes are respected without exception.</li>
      <li>Secondary use must align with original consent language.</li>
      <li>De‑identified data may be used for internal validation and QA.</li>
      <li>External collaborators receive only de‑identified datasets.</li>
    </ul>
  </section>


  <!-- Data protections -->
  <section class="panel-light section-tight">
    <h2>Data protection safeguards</h2>

    <ul class="list-tight">
      <li>Industry‑standard encryption and access controls.</li>
      <li>SOP‑driven lab and data workflows.</li>
      <li>Segregated environments for PHI vs. de‑identified datasets.</li>
      <li>Regular internal and external security reviews.</li>
      <li>Retention and deletion based on regulatory guidelines.</li>
    </ul>
  </section>


  <!-- LDT Compliance -->
  <section class="section-tight">
    <h2>CLIA LDT compliance</h2>

    <p>
      LiquidMammo is developed and validated under CLIA Laboratory Developed Test practices.
    </p>

    <ul class="list-tight" style="margin-top:10px;">
      <li>CLIA‑certified laboratory environment.</li>
      <li>Analytical accuracy, precision, and reproducibility validation.</li>
      <li>Quality management and proficiency testing.</li>
      <li>Comprehensive documentation and SOPs.</li>
    </ul>
  </section>


  <!-- Data access requests -->
  <section id="data-use" class="panel-light section-tight">
    <h2>Data access requests</h2>

    <p class="small">
      Researchers requesting data access must submit a brief concept note outlining study aims.
      Only de‑identified datasets are eligible for release.
    </p>

    <div style="margin-top:14px;">
      contact.html#partnersSubmit a request</a>
    </div>
  </section>


  <!-- FAQ -->
  <section class="section-tight">
    <h2>Frequently asked</h2>

    <div class="grid" style="grid-template-columns:repeat(auto-fit, minmax(260px,1fr)); margin-top:18px;">

      <div class="card-mini">
        <h4>Do you sell or share patient data?</h4>
        <p class="small">Never. Data is not sold or used for marketing.</p>
      </div>

      <div class="card-mini">
        <h4>Do research partners receive PHI?</h4>
        <p class="small">
          No. Only de‑identified datasets may be shared following review and approval.
        </p>
      </div>

      <div class="card-mini">
        <h4>How long is data retained?</h4>
        <p class="small">
          Retention follows CLIA, HIPAA, and state regulatory requirements.
        </p>
      </div>

    </div>
  </section>

</main>


<!-- ======================================
     FOOTER
======================================= -->
<footer>
  <div class="container footer-grid">

    <div>
      <strong>LiquidMammo™</strong><br />
      A test developed by MultiOmics Inc.
      <p class="footer-note">
        MultiOmics Inc. is headquartered in Washington, DC,
        and operates out of LabCentral in Cambridge, MA.
      </p>
    </div>

    <div class="footer-logo" style="justify-content:flex-end; text-align:right;">
      assets/logos/multiomics-logo.png
      <div class="footer-note" style="line-height:1.2">
        Developed by<br />MultiOmics Inc.
      </div>
    </div>

  </div>

  <div class="container footer-note" style="margin-top:20px;">
    © <script>document.write(new Date().getFullYear())</script>
    MultiOmics Inc. •
    privacy.htmlPrivacy & Compliance</a> •
    contact.htmlContact</a>
  </div>
</footer>

</body>
</html>
